The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study

• Published in: Gynecologic oncology Vol. 99; no. 1; pp. 36 - 42
• Main Authors: Akhan, Suleyman Engin, Yavuz, Ekrem, Tecer, Aysegul, İyibozkurt, Cem Ahmet, Topuz, Samet, Tuzlalı, Sıtkı, Bengisu, Ergin, Berkman, Sinan
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.10.2005
• Subjects: Adult; Aged; Estrogen receptor; Female; Humans; Immunohistochemistry; Ki-67; Ki-67 Antigen - biosynthesis; Leiomyosarcoma; Leiomyosarcoma - metabolism; Leiomyosarcoma - pathology; Middle Aged; Neoplasm Staging; p53; Progesterone receptor; Prognosis; Receptors, Estrogen - biosynthesis; Receptors, Progesterone - biosynthesis; Retrospective Studies; Tumor Suppressor Protein p53 - biosynthesis; Uterine Neoplasms - metabolism; Uterine Neoplasms - pathology; Ki-67; Estrogen receptor; Progesterone receptor; Leiomyosarcoma; p53
• ISSN: 0090-8258; 1095-6859
• DOI: 10.1016/j.ygyno.2005.05.019

To evaluate the level of expression of estrogen receptor (ER), progesterone receptor (PR), p53 and Ki-67 in patients with leiomyosarcoma and to investigate the effect of these and to identify the clinical parameters on prognosis. Twenty-four patients operated for LMS of uterine origin between 1994 and 2003 at Istanbul Medical School, Department of Obstetrics and Gynecology and Division of Gynecologic Oncology constituted our study group. The data of all patients were updated via mail or phone. The effects of stage, grade, chemotherapy, radiotherapy, number of mitoses, presence of necrosis, Ki-67 and p53 expression, presence of estrogen and progesterone receptors on survival were evaluated. The mean follow-up period of patients is 30.42 ± 25.15 months. The mean overall survival for all LMS patients was estimated to be 48.4 ± 10.38 months. The cumulative survival ratio in the 33rd month was 33.08. Age, menopausal status, history of prior radiotherapy, number of mitoses had no statistically significant effect on overall survival in our study although stage had a significant effect. Finding of greater than 10% steroid receptor expression has a positive effect on survival ([ER P = 0.019; log rank = 5.49] and [PR P = 0.023; log rank = 5.14]). The median value of Ki-67 was calculated to be 30. There was a survival advantage in patients with Ki-67 expression ( P = 0.034; log rank = 4.49) below the median value. p53 levels had no significant effect on survival ( P = 0.336; log rank = 0.92). Surgical staging is an important prognostic factor in LMS patients, while number of mitoses and grade of the tumor also seem to affect prognosis. Contrary to the current literature, our findings suggest that estrogen and progesterone receptor positivity greater than 10% may be associated with a better prognosis.